Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?

2003 ◽  
Vol 8 (2) ◽  
pp. 94-108 ◽  
Author(s):  
Ricardo Caceda ◽  
Becky Kinkead ◽  
Charles B. Nemeroff
Keyword(s):  
Antipsychotic Drugs ◽  
Receptor Agonists ◽  
Neurotensin Receptor

Neurotensin receptor agonists and antagonists

1993 ◽  
Vol 18 (12) ◽  
pp. 1137 ◽  
Author(s):  
J.P. Maffrand ◽  
D. Gully ◽  
R. Boigegrain ◽  
P. Soubrie ◽  
P. Kitabgi ◽  
...  
Keyword(s):  
Receptor Agonists ◽  
Neurotensin Receptor ◽  
Receptor Agonists And Antagonists

The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio

2019 ◽  
Vol 848 ◽  
pp. 80-87 ◽  
Author(s):  
Emilie Eiselt ◽  
Jérôme Côté ◽  
Jean-Michel Longpré ◽  
Véronique Blais ◽  
Philippe Sarret ◽  
...  
Keyword(s):  
Adverse Effect ◽  
Receptor Agonists ◽  
Neurotensin Receptor ◽  
Effect Ratio

Neurotensin Receptor Agonists and Antagonists for Schizophrenia

2005 ◽  
Vol 162 (3) ◽  
pp. 633-b-634 ◽  
Author(s):  
ELLIOTT RICHELSON ◽  
PAUL A. FREDRICKSON ◽  
MONA M. BOULES
Keyword(s):  
Receptor Agonists ◽  
Neurotensin Receptor ◽  
Receptor Agonists And Antagonists

Abstract #295 GLP-1 Receptor Agonists and Death From Any Cause in Elderly Patients with Type 2 Diabetes Mellitus: A Post-Hoc Analysis

2018 ◽  
Vol 24 ◽  
pp. 80-81
Author(s):  
Konstantinos Toulis ◽  
Krishna Gokhale ◽  
G. Neil Thomas ◽  
Wasim Hanif ◽  
Krishnarajah Nirantharakumar ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Elderly Patients ◽  
Post Hoc Analysis ◽  
Receptor Agonists ◽  
Post Hoc
Sign in / Sign up

Export Citation Format

Share Document